Health

  • Women who perform domestic chores have better bone health
    New York, October 26 (IANS): Women who spend a substantial amount of time doing domestic chores such as growing fruits and vegetables, churning butter, beating rugs, washing windows and caring for children have better bone density and overall bone health than women leading sedentary lifestyles, new research has found. Previous studies in the field have looked at bone density measurements in menopausal women. This time, the researchers from Beckman Institute for advanced Science a
  • Oxford COVID-19 vaccine prompts immune response among adults old and young, AstraZeneca says
    LONDON, October 26 (Reuters) - The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc said on Monday. A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world. &quo
  • 'Indian women diagnosed with more aggressive breast cancer very early'
    New York, October 25 (IANS): In a major US study, researchers, including one of Indian-origin, have found that Indian and Pakistani women are diagnosed with breast cancer, including more aggressive forms of the disease, at a younger age. The study, published in the International Journal of Cancer, examined the characteristics of breast cancer in Indian- and Pakistani-American and non-Hispanic white women in the US. "Our results provide an insight into breast cancer in Indian
  • Covid-19 a double blow for chronic disease patients in India: Study
    Sydney, October 24 (IANS): Researchers have revealed that Covid-19 pandemic came as a double blow for people with non-communicable diseases (NCDs) such as diabetes, cancer, respiratory problems or cardiovascular conditions in countries like India, Bangladesh, Pakistan and others. The study, published in the journal Frontiers in Public Health, found people with NCDs are more vulnerable to catching and dying from Covid-19 and their exposure to NCD risk factors - such as substance abus
  • Most people would get COVID-19 vaccine if offered by government or employer: poll
    LONDON, October 21 (Reuters) - Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid growing concerns about public distrust of the shots being developed at speed to end the pandemic. Some 71.5% of participants said they would be very or somewhat likely to take a COVID-19 vaccine and 61.4% reported they would accept their employer's recommendation to do so, according to the survey in June of more
  • Covid vaccinations make many people anxious worldwide: Study
    London, October 21 (IANS): Scientists have found that many people around the world are 'hesitant' about a Covid-19 vaccine and the reason is strongly related to lack of trust in their government. In a study, published in the journal 'Nature Medicine', the research team validated sample of over 13,400 individuals from 19 countries, including India, that have been hard-hit by the virus and found that 72 per cent of participants would likely take the vaccine. Of the
  • Air pollution may up risk of neurological disorders: Study
    New York, October 20 (IANS): New research adds to the growing body of evidence that air pollution is significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson's disease, Alzheimer's disease, and other dementias. For the study, published in the journal The Lancet Planetary Health, the research team analysed the link between fine particulate (PM2.5) pollution and neurodegenerative diseases in the US. Parti
  • China's Sinovac vaccine is safe, Brazil institute says
    BEIJING/SAO PAULO, October 20 (Reuters) - An experimental coronavirus vaccine developed by China's Sinovac Biotech appeared to be safe in a late-stage clinical trial in Brazil, preliminary results showed on Monday. São Paulo's Butantan Institute, one of Brazil's leading biomedical research centers, which is carrying out the Phase 3 tests, said the two-dose vaccine, called CoronaVac, proved to be safe in a trial so far involving 9,000 volunteers. But Butantan di
  • First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people
    MOSCOW, October 20 (Reuters) - Preliminary results from the late-stage human trial of Russia's main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday. Russia's plan to publish preliminary data about the Sputnik V jab as early as November is likely to make it one of the first vaccine developers to share any data from a final stage trial, known as Phase
  • Have nutritional beverage with exercise for fit body, sharp mind
    New York, October 19 (IANS): Daily exercise, along with nutrient-enriched beverages, can do wonder with improving both physical and cognitive health, researchers have discovered. While exercise alone improved strength and endurance, mobility and stability, those who also consumed the nutritional supplement as part of the study saw all of these improvements and more. "For example, they were better able to retain new information in their working memory and had quicker response
  • WHO warns against complacency in view of declining Covid cases
    New Delhi, October 19 (IANS): The World Health Organisation (WHO) on Monday cautioned against any relaxation of response actions following the recent slight decline in Covid-19 cases in South-East Asia Region, saying the pandemic continues unabated and our response only needs to be strengthened further to curtail virus transmission. "There should be no complacency in view of the declining numbers in recent weeks. The Region still reports large numbers of Covid-19 cases. We need
  • Sputnik V Covid-19 vaccine gets nod for clinical trials in India
    New Delhi, October 17 (IANS): The Drug Controller General of India (DCGI) has granted approval to Dr Reddy's, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human trials of the Sputnik V, a Covid-19 vaccine made by Russia. On September 16, the Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Limited had agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India. Sputnik V, an a
  • Q&A: Where are we in the COVID-19 vaccine race?
    NEW YORK (Reuters) - Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. As some companies close in on unveiling their initial findings - with Canadian and European regulators already reviewing early data on some vaccines - the following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed
  • China's Covid-19 vax is safe, prompts antibody response: Lancet
    Beijing, October 16 (IANS): Chinese Covid-19 vaccine candidate -- BBIBP-CorV -- that is expected to completely inactivate the SARS-CoV-2 virus, is safe and elicits an antibody response, a study published in The Lancet has found. A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested on people aged under 60 years. The latest study reported in The Lancet Infec
  • Pfizer sees emergency use filing for COVID-19 vaccine after U.S. election
    October 16 (Reuters) - Pfizer Inc expects to provide safety data and file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, delaying any clarity on the vaccine until after the Nov. 3 U.S. presidential election. The regulatory filing for the vaccine could come as soon as safety data is available in the third week of November, Pfizer said, lifting the company's shares and the broader U.S. stock market. The timeline now all
  • People with blood type O may have a lower risk of Covid-19: Study
    London, October 15 (IANS): New research adds to the growing body of evidence that people with blood type 'O' may have a lower risk of Covid-19 infection and reduced likelihood of severe outcomes, including organ complications if they do get sick. Two studies published in the journal Blood Advances suggest that individuals with blood type 'O' may be less vulnerable to Covid-19 infection. "It is very important to consider the proper control group because blood
  • Handwashing an effective tool to prevent Covid, other diseases: WHO
    New Delhi, October 15 (IANS): Ten months into the pandemic, handwashing with soap remains one of our best defences against the virus, along with other public health measures such as maintaining physical distance, avoiding crowded places, practising cough etiquette and wearing a mask wherever recommended. Global Handwashing Day observed annually on October 15 to raise awareness and highlight the importance of handwashing as an effective means of disease prevention -- this year marks
  • Handwashing an effective tool to prevent Covid, other diseases: WHO
    New Delhi, October 15 (IANS): Ten months into the pandemic, handwashing with soap remains one of our best defences against the virus, along with other public health measures such as maintaining physical distance, avoiding crowded places, practising cough etiquette and wearing a mask wherever recommended. Global Handwashing Day observed annually on October 15 to raise awareness and highlight the importance of handwashing as an effective means of disease prevention -- this year marks
  • Russia approves second COVID-19 vaccine after preliminary trials
    MOSCOW, October 14 (Reuters) - Russia has granted regulatory approval to a second COVID-19 vaccine, according to its register of authorised medicines. A delighted President Vladimir Putin announced the news at a government meeting on Wednesday. The jab was developed by the Vector Institute in Siberia and completed early-stage human trials last month. However, results have not been published yet and a large-scale trial, known as Phase III, has not yet begun. "We need to in
  • Sanitising-gel poisoning cases soar among Spanish children amid pandemic
    MADRID, October 14 (Reuters) - The number of Spanish children treated for poisoning after ingesting hand-sanitising gels has rocketed as the product has become ubiquitous during the coronavirus pandemic. The Spanish National Toxicological and Forensic Institute said on Wednesday the total reported intoxications from those gels so far this year, at 874, was almost 10 times the number reported in all of 2019. Children, especially toddlers, accounted for almost two-thirds of the cas